Memphasys (ASX:MEM) FCF Margin %: -10,291.67% (As of Dec. 2025)


What is Memphasys FCF Margin %?

Memphasys ASX:MEM FCF Margin % is -10,291.67% as of Dec. 2025. The stock has 5 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Memphasys ranks worse than 99.26% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Memphasys's Free Cash Flow for the six months ended in Dec. 2025 was A$-1.24 Mil. Memphasys's Revenue for the six months ended in Dec. 2025 was A$0.01 Mil. Therefore, Memphasys's FCF Margin % for the quarter that ended in Dec. 2025 was -10,291.67%.

As of today, Memphasys's current FCF Yield % is -16.68%.

The historical rank and industry rank for Memphasys's FCF Margin % or its related term are showing as below:

ASX:MEM' s FCF Margin % Range Over the Past 10 Years
Min: -80525   Med: -9670.37   Max: -1993.75
Current: -27708.33

During the past 13 years, the highest FCF Margin % of Memphasys was -1993.75%. The lowest was -80525.00%. And the median was -9670.37%.

ASX:MEM's FCF Margin % is ranked worse than
99.26% of 815 companies
in the Medical Devices & Instruments industry
Industry Median: -0.03 vs ASX:MEM: -27708.33

Memphasys FCF Margin % Related Terms

Memphasys FCF Margin % Historical Data

* Premium members only.

The historical data trend for Memphasys's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Memphasys FCF Margin % Chart

Memphasys Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -9,670.37 -21,526.67 -6,448.33 -80,525.00

Memphasys Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3,966.67 -10,175.00 -28,275.00 0.00 -10,291.67

ASX:MEM vs ABT, SYK, MDT: FCF Margin % Comparison

For the Medical Devices subindustry, Memphasys's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Memphasys FCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Memphasys's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Memphasys's FCF Margin % falls into.


Memphasys FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Memphasys's FCF Margin for the fiscal year that ended in Jun. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-3.221/0.004
=-80,525.00 %

Memphasys's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-1.235/0.012
=-10,291.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -10,291.67% mean?
Memphasys (ASX:MEM) has a FCF Margin % of -10,291.67% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Memphasys and its competitors. According to the industry distribution chart, Memphasys ranks #809 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 99.3%.
Is Memphasys' FCF Margin % too high?
Memphasys' current FCF Margin % is -10,291.67%. Based on the distribution chart, Memphasys ranks #809 out of 815 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Memphasys' FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Memphasys ranks #809 out of 815 companies for FCF Margin %. This places Memphasys in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Memphasys and its competitors. Memphasys's current FCF Margin % is -10,291.67%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Memphasys stock overvalued right now?
Memphasys (ASX:MEM) has a current FCF Margin % of -10,291.67%. The current FCF Margin % is -10,291.67%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Memphasys (ASX:MEM), the current FCF Margin % is -10,291.67% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Memphasys Business Description

Other Exchanges IG7:Germany
Address 34-36 Richmond Road, Level 1, Homebush West, Sydney, NSW, AUS, 2140
Memphasys Ltd is an Australian reproductive biotechnology company developing and commercializing novel reproduction and fertility solutions for humans and animals. The products in its development pipeline include a range of devices, media, and in vitro diagnostic solutions. The company is currently focused on the commercialisation of its patented Felix System, a novel bio-separation technology for assisted reproduction, designed to revolutionise sperm separation in assisted reproductive technology (ART) by providing a rapid, gentle, and automated process. The group has only one operating segment, being Reproductive Technologies, the assets and liabilities of which are located in Australia.